IMHO-- Institutions would not be jumping into this stock at the moment whatever the price. Some reasons why: lack of understanding in regard to the science, interim ceo, misperception about destroying embryos, trials that have been postponed many times, many similar companies making GREAT claims (many later proven wrong), history of virtual bankruptcy, etc etc... I believe that Rabin/mgt and Terren P will do what is best to protect our/their interest---a high mkt cap and pps in due time. I offer no advice as I have made a BUNCH of BAD financial decisions in the past---but I am long and holding on. GLTA
